Needham & Company Reiterates a 'Buy' on Aegerion Pharmaceuticals (AEGR); Profitability By 2014

Go back to Needham & Company Reiterates a 'Buy' on Aegerion Pharmaceuticals (AEGR); Profitability By 2014